程序性死亡受体1抑制剂联合化疗治疗复发难治经典型霍奇金淋巴瘤完全缓解二例

著录项

• 来源
  《白血病·淋巴瘤》 |2019年第4期|233-235|共3页
• 作者

  Zhang Yarui; Wang Huaqing; Song Teng; Chang Zhi; Zou Dandan; Li Shuping; Chen Haizhu; Zhao Ke; Li Xiang;

  展开▼
• 作者单位

  Department of Oncology 3 (Department of Lymphatic Hematology), Cancer Diagnosis Center of the Peopleˊs Hospital of Tianjin, Cancer Research Institute of Integrated Traditional Chinese and Western Medicine in Tianjin, Tianjin 300121, China;

  Department of Oncology 3 (Department of Lymphatic Hematology), Cancer Diagnosis Center of the Peopleˊs Hospital of Tianjin, Cancer Research Institute of Integrated Traditional Chinese and Western Medicine in Tianjin, Tianjin 300121, China;

  Department of Oncology 3 (Department of Lymphatic Hematology), Cancer Diagnosis Center of the Peopleˊs Hospital of Tianjin, Cancer Research Institute of Integrated Traditional Chinese and Western Medicine in Tianjin, Tianjin 300121, China;

  Department of Oncology 3 (Department of Lymphatic Hematology), Cancer Diagnosis Center of the Peopleˊs Hospital of Tianjin, Cancer Research Institute of Integrated Traditional Chinese and Western Medicine in Tianjin, Tianjin 300121, China;

  Department of Oncology 3 (Department of Lymphatic Hematology), Cancer Diagnosis Center of the Peopleˊs Hospital of Tianjin, Cancer Research Institute of Integrated Traditional Chinese and Western Medicine in Tianjin, Tianjin 300121, China;

  Department of Oncology 3 (Department of Lymphatic Hematology), Cancer Diagnosis Center of the Peopleˊs Hospital of Tianjin, Cancer Research Institute of Integrated Traditional Chinese and Western Medicine in Tianjin, Tianjin 300121, China;

  Department of Oncology 3 (Department of Lymphatic Hematology), Cancer Diagnosis Center of the Peopleˊs Hospital of Tianjin, Cancer Research Institute of Integrated Traditional Chinese and Western Medicine in Tianjin, Tianjin 300121, China;

  Department of Oncology 3 (Department of Lymphatic Hematology), Cancer Diagnosis Center of the Peopleˊs Hospital of Tianjin, Cancer Research Institute of Integrated Traditional Chinese and Western Medicine in Tianjin, Tianjin 300121, China;

  Department of Oncology 3 (Department of Lymphatic Hematology), Cancer Diagnosis Center of the Peopleˊs Hospital of Tianjin, Cancer Research Institute of Integrated Traditional Chinese and Western Medicine in Tianjin, Tianjin 300121, China;

  展开▼
• 原文格式 PDF
• 正文语种 chi
• 中图分类
• 关键词

  经典型霍奇金淋巴瘤; 复发难治; PD_1抑制剂; 纳武单抗;